MMC
60
6
FMC
33
2
SIG
49
6
AEP
53
2
HPE
61
6
MA
57
2
ZTS
49
2
EQR
59
5
HAL
60
2
MAS
56
5
AIV
70
2
CINF
51
4
KMX
64
6
SEE
52
6
CNP
63
3
AMZN
55
-3
EXPE
91
3
DOW
34
4
EOG
56
-2
C
60
2
MMC
60
6
FMC
33
2
SIG
49
6
AEP
53
2
HPE
61
6
MA
57
2
ZTS
49
2
EQR
59
5
HAL
60
2
MAS
56
5
AIV
70
2
CINF
51
4
KMX
64
6
SEE
52
6
CNP
63
3
AMZN
55
-3
EXPE
91
3
DOW
34
4
EOG
56
-2
C
60
2
Financhill
Back

Regenxbio Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
18

RGNX
Regenxbio

Last Price:
9.21
Seasonality Move:
-5.66%
Buy
55

EYPT
EyePoint Pharmaceuticals

Last Price:
8.35
Seasonality Move:
28.93%
Sell
18
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.18. The Score for RGNX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.35. The Score for EYPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.02 Sell
Chaikin Money Flow: -473643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.97 - 10.71) Sell
Bollinger Bands (100): (9.86 - 12.8) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 35.82 Sell
Chaikin Money Flow: -1872551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.53 - 11.89) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.06 Sell
20-day SMA: 9.77 Sell
50-day SMA: 10.34 Sell
200-day SMA: 14.27 Sell
8-day EMA: 9.84 Sell
20-day EMA: 9.96 Sell
50-day EMA: 10.39 Sell
200-day EMA: 13.22 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.58 Sell
20-day SMA: 10.78 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.55 Sell
8-day EMA: 9.47 Sell
20-day EMA: 10.14 Sell
50-day EMA: 9.98 Sell
200-day EMA: 11.48 Sell

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):